Search

Search Constraints

You searched for: Author/Creator Singer, Daniel E

Search Results

1. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillation. Issue 5 (18th September 2018)

2. Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation. Issue 22 (6th June 2018)

3. Decline in renal function and oral anticoagulation dose reduction among patients with atrial fibrillation. Issue 5 (7th January 2020)

4. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF). Issue 9985 (13th June 2015)

5. Disease understanding in patients newly diagnosed with atrial fibrillation. Issue 6 (8th August 2017)

6. Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban. Issue 13 (17th February 2016)

7. Patterns of oral anticoagulation use with cardioversion in clinical practice. Issue 8 (26th June 2020)

8. Patterns of oral anticoagulation use with cardioversion in clinical practice. Issue 8 (26th June 2020)